Steve Engle

Biography

Mr Engle served as VP of Marketing for Cygnus, a drug delivery company, where he helped gain FDA approval of and launch Nicotrol for smoking cessation. He was VP of Marketing at a $50 million device company and a management consultant at Strategic Decisions Group and SRI (Stanford Research Institute) International. Mr Engle is a Board member of Anthera Pharmaceuticals with clinical stage products in lupus and enzyme replacement, Prescient Therapeutics (ASX: PTX) with clinical stage oncology products, and AROA Biosurgery, a privately held developer of regenerative medicine products. Mr Engle is a former Board member of BIO, Baybio, BIOCOM and the Lupus Foundation of America. Mr Engle holds a B.S. and an M.S. in electrical engineering with a focus in biomedical engineering from the University of Texas at Austin.

Research Interest

Biotechnology